
Quest Diagnostics announced a quarterly cash dividend of $0.86 per share, payable on July 22, 2026, to shareholders recorded by July 8, 2026. This dividend reflects the company's ongoing commitment to returning value to shareholders. Quest Diagnostics is a major player in diagnostic services, serving half of U.S. physicians and hospitals and one in three American adults annually. The dividend payment highlights the company’s financial health and shareholder focus.